BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2343913)

  • 1. Effects of chronic cocaine abuse on postsynaptic dopamine receptors.
    Volkow ND; Fowler JS; Wolf AP; Schlyer D; Shiue CY; Alpert R; Dewey SL; Logan J; Bendriem B; Christman D
    Am J Psychiatry; 1990 Jun; 147(6):719-24. PubMed ID: 2343913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET).
    Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND
    Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113
    [No Abstract]   [Full Text] [Related]  

  • 3. Cocaine uptake is decreased in the brain of detoxified cocaine abusers.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemannn R; Gatley SJ; MacGregor RR; Wolf AP
    Neuropsychopharmacology; 1996 Mar; 14(3):159-68. PubMed ID: 8866699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia.
    Wolkin A; Barouche F; Wolf AP; Rotrosen J; Fowler JS; Shiue CY; Cooper TB; Brodie JD
    Am J Psychiatry; 1989 Jul; 146(7):905-8. PubMed ID: 2568094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients.
    Smith M; Wolf AP; Brodie JD; Arnett CD; Barouche F; Shiue CY; Fowler JS; Russell JA; MacGregor RR; Wolkin A
    Biol Psychiatry; 1988 Apr; 23(7):653-63. PubMed ID: 2967093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
    Volkow ND; Fowler JS; Wang GJ; Hitzemann R; Logan J; Schlyer DJ; Dewey SL; Wolf AP
    Synapse; 1993 Jun; 14(2):169-77. PubMed ID: 8101394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
    Arnett CD; Wolf AP; Shiue CY; Fowler JS; MacGregor RR; Christman DR; Smith MR
    J Nucl Med; 1986 Dec; 27(12):1878-82. PubMed ID: 3491193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between subjective effects of cocaine and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE
    Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects.
    Schlaepfer TE; Pearlson GD; Wong DF; Marenco S; Dannals RF
    Am J Psychiatry; 1997 Sep; 154(9):1209-13. PubMed ID: 9286178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients.
    Yousef KA; Volkow ND; Schlyer DJ; Fowler JS; Wolf AP; Wang GJ; Smith MR; Brodie JD; Warner D
    Synapse; 1995 Jan; 19(1):14-7. PubMed ID: 7709339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography.
    Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in brain glucose metabolism in cocaine dependence and withdrawal.
    Volkow ND; Fowler JS; Wolf AP; Hitzemann R; Dewey S; Bendriem B; Alpert R; Hoff A
    Am J Psychiatry; 1991 May; 148(5):621-6. PubMed ID: 2018164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endogenous dopamine on measures of [18F]N-methylspiroperidol binding in the basal ganglia: comparison of simulations and experimental results from PET studies in baboons.
    Logan J; Dewey SL; Wolf AP; Fowler JS; Brodie JD; Angrist B; Volkow ND; Gatley SJ
    Synapse; 1991 Nov; 9(3):195-207. PubMed ID: 1685599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; Hitzemann R; Chen AD; Dewey SL; Pappas N
    Nature; 1997 Apr; 386(6627):830-3. PubMed ID: 9126741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine receptors on dopamine transporters are related to self-administration of cocaine.
    Ritz MC; Lamb RJ; Goldberg SR; Kuhar MJ
    Science; 1987 Sep; 237(4819):1219-23. PubMed ID: 2820058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine abusers do not show loss of dopamine transporters with age.
    Wang GJ; Volkow ND; Fowler JS; Fischman M; Foltin R; Abumrad NN; Logan J; Pappas NR
    Life Sci; 1997; 61(11):1059-65. PubMed ID: 9307051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.